Evaluation of long-term anti-Spike immune response following a novel coronavirus vaccine (CORVax): electroporation of SARS-CoV-2 Spike plasmid DNA plus plasmid IL-12

Bernard A Fox

Evaluation of long-term anti-Spike immune response following a novel coronavirus vaccine (CORVax): electroporation of SARS-CoV-2 Spike plasmid DNA plus plasmid IL-12

Research output: Other contribution

Original language	American English
State	Published - May 1 2022

Publication series

Name	Articles, Abstracts, and Reports

Access to Document

http://digitalcommons.providence.org/publications/6155

Cite this

@misc{29a3bdc78b2a4c15a432cb938e02ee5a,

title = "Evaluation of long-term anti-Spike immune response following a novel coronavirus vaccine (CORVax): electroporation of SARS-CoV-2 Spike plasmid DNA plus plasmid IL-12",

author = "Fox, {Bernard A}",

year = "2022",

month = may,

day = "1",

language = "American English",

series = "Articles, Abstracts, and Reports",

type = "Other",

}